Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease
American Journal of Medical Genetics Part A · 2026-12 · 200 (12) · 2608-2615
DOI: 10.1002/ajmg.a.70237 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 30.06.2026. Verfasst von Reem M Elshafie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Medical Genetics Center, Ministry of Health, Sulaibikhat, Kuwait. Hauptthemen laut MEDLINE: Alleles, Bone Diseases, Developmental, Extracellular Matrix Proteins, Genetic Predisposition to Disease. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Research, Development, and Innovation Authority, Kingdom of Saudi Arabia.
Abstract (Originalsprache)
Hyaluronan and proteoglycan link protein 1 encodes HAPLN1, a critical structural protein in the extracellular matrix (ECM), essential for maintaining tissue architecture and integrity. HAPLN1 mediates stable interactions between hyaluronan and proteoglycans, crucial elements of the ECM that confer structural stability, elasticity, and functional regulation to connective tissues. Aberrations in HAPLN1 expression or function have been implicated in various pathological conditions, including inflammation and tumorigenesis in humans and skeletal dysplasias in mice. To the best of our knowledge, HAPLN1 has not been implicated in human skeletal dysplasia. Herein, we report a novel homozygous missense variant in HAPLN1 in four individuals from an extended consanguineous Kuwaiti family, co‐segregating with a skeletal dysplasia phenotype. Affected individuals presented with shortened long bones of both upper and lower limbs, square‐shaped iliac wings, narrowed sciatic notches, flattened acetabular roofs, progressive narrowing of the lumbar interpedicular distance with widened intervertebral disc spaces, and short, stubby metacarpal bones. Our findings identify HAPLN1 as a candidate gene underlying a newly described autosomal recessive skeletal dysplasia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kuwait Medical Genetics Center, Ministry of Health, Sulaibikhat, Kuwait.
- Department of Pediatrics, College of Medicine, Kuwait University, Safat, Kuwait.
- Department of Pediatrics, Farwaniya Hospital, Ministry of Health, Sabah Al-Nasser, Kuwait.
- Department of Radiology, Jahra Hospital, Ministry of Health, Al Jahra, Kuwait.
- Center for Genetics and Inherited Diseases, Taibah University, Almadinah Almunwarah, Saudi Arabia.
- Faculty of Applied Medical Sciences, Taibah University, Almadinah Almunwarah, Saudi Arabia.
ORCID-Profile: Reem M Elshafie, Hind Alsharhan, Naif A M Almontashiri, Dana Marafi
Förderung
- Research, Development, and Innovation Authority, Kingdom of Saudi Arabia
Zitieren
APA
Elshafie, R. M., Alsharhan, H., Abulabqah, H., Janicijevic, A., Alrashidi, N. H., Omar, S., Bastaki, L., Almontashiri, N. A. M., & Marafi, D. (2026). Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease. American Journal of Medical Genetics Part A, 200(12), 2608-2615. https://doi.org/10.1002/ajmg.a.70237
Vancouver
Elshafie RM, Alsharhan H, Abulabqah H, Janicijevic A, Alrashidi NH, Omar S, et al. Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease. American Journal of Medical Genetics Part A. 2026;200(12):2608-2615. doi:10.1002/ajmg.a.70237
BibTeX
@article{Elshafie2026,
author = {Elshafie, Reem M and Alsharhan, Hind and Abulabqah, Hanai and Janicijevic, Aleksander and Alrashidi, Nuwayer H and Omar, Sherif and Bastaki, Laila and Almontashiri, Naif A M and Marafi, Dana},
title = {Biallelic Variant in HAPLN1 is Associated With Skeletal Dysplasia With or Without Congenital Heart Disease},
journal = {American Journal of Medical Genetics Part A},
year = {2026},
volume = {200},
number = {12},
pages = {2608--2615},
doi = {10.1002/ajmg.a.70237}
}
EUVIMED